Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Minoxidil can cause hair growth as a side effect.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Combining fractional CO2 laser or microneedling with 5-FU is more effective and safer for treating vitiligo.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Tacalcitol ointment effectively improves bilateral nevus comedonicus.

Young patients with Vogt-Koyanagi-Harada syndrome may have poor vision outcomes despite treatment due to frequent recurrences.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Divalproex sodium significantly improved headaches in two-thirds of patients.

FUE with topical CBD effectively treats stable vitiligo.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.